Over The Counter (OTC) Analgesics or painkillers are drugs that act at different quantity of a pain transmission pathway. Aspirin along with non-steroidal anti-inflammatory agents (NSAIDs) and many more act peripherally, although some others agents, for instance opioids act for the central nervous system (CNS). While anticonvulsants act on neurogenic pain, muscle relaxants act on pain because of muscle spasm. These analgesics are helpful in pain management; however, skin adverse effects.
The reasons behind the growth in the OTC analgesics market
· Increasing interest in topical analgesics, which one can find as pain-relieving creams, lotions, rubs, gels, and sprays. This has increased the sale of analgesics by 18%, based on Kline Nonprescription Drugs USA report.
· Increasing global geriatric human population is expected to generate higher requirement for pain relief products. In the United States, about 23% on the people were supposed to cross 55 yrs old in 2015.
· Product innovation to boost performance, when it comes to speed and strength, and further, increase the length in the effect.
· Cost saving, mindful about would be no requirement to visit a doctor/physician. It is estimated that the US healthcare system saves USD 6-7 for any USD 1 used on OTC medicines.
However, anything in too much can take a toll and it’s no different with OTC analgesics. The common side-effects include constipation, drowsiness, dizziness, upset stomach, cardiac arrest or stroke. These drugs may cause serious alterations in the brain and the entire body. Long-term using painkillers increases addiction and dependency within the drugs. In the United States, painkillers would be the second most abused substances, after marijuana. Pain, in a few form or other, is an element of one’s everyday life, hence, the advantages of painkillers.
A report by way of a market research firm estimates a double-digit growth rate for your Global OTC Analgesics Market, estimated to be a market worth USD 20.79 billion by 2022.
The OTC analgesics marketplace is driven from the better performance of premium-priced branded products compared to generic OTC analgesics.
Hurdles with the market include:
Uncontrolled prescription of opioids, drug use, and unregulated government policies are being hurdles with this market.